Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 68.57B | 64.47B | 56.46B | 43.85B | 37.85B |
Gross Profit | 15.55B | 14.60B | 12.55B | 9.51B | 7.86B |
EBITDA | 3.03B | 2.45B | 1.20B | -307.00M | -1.54B |
Net Income | 1.75B | 2.01B | 832.00M | -727.00M | -1.86B |
Balance Sheet | |||||
Total Assets | 22.97B | 24.86B | 20.79B | 17.67B | 17.94B |
Cash, Cash Equivalents and Short-Term Investments | 4.01B | 6.51B | 4.22B | 3.54B | 4.38B |
Total Debt | 1.78B | 4.56B | 4.88B | 6.38B | 6.93B |
Total Liabilities | 15.04B | 18.20B | 16.35B | 14.90B | 14.45B |
Stockholders Equity | 7.92B | 6.67B | 4.44B | 2.78B | 3.50B |
Cash Flow | |||||
Free Cash Flow | 413.00M | 2.68B | 1.58B | -401.00M | -3.42B |
Operating Cash Flow | 664.00M | 3.56B | 2.01B | -238.00M | -3.07B |
Investing Cash Flow | -211.00M | -868.00M | -499.00M | 357.00M | -88.00M |
Financing Cash Flow | -3.01B | -442.00M | -851.00M | -576.00M | 3.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥7.43B | 4.41 | 0.90% | 6.35% | -12.65% | ||
73 Outperform | ¥10.95B | 71.42 | ― | 20.21% | 138.50% | ||
71 Outperform | ¥6.98B | 14.47 | 1.06% | 8.35% | 49.38% | ||
69 Neutral | ¥4.48B | 3.81 | 1.79% | 0.86% | 17.20% | ||
68 Neutral | ¥8.30B | 15.86 | 2.46% | 6.31% | 101.07% | ||
65 Neutral | £10.64B | 8.72 | 3.35% | 285.19% | -1.40% | 17.93% | |
57 Neutral | ¥7.68B | 26.62 | 1.02% | 6.33% | 40.40% |